These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 22290405)

  • 41. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection.
    Zipursky JS; Sidorsky TI; Freedman CA; Sidorsky MN; Kirkland KB
    Clin Infect Dis; 2012 Dec; 55(12):1652-8. PubMed ID: 22990849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal microbiota transplantation for management of Clostridium difficile infection.
    Vaishnavi C
    Indian J Gastroenterol; 2014 Jul; 33(4):301-7. PubMed ID: 24748025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal transplant for recurrent Clostridium difficile infection.
    Lofland D; Josephat F; Partin S
    Clin Lab Sci; 2013; 26(3):131-5. PubMed ID: 23967542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.
    Drekonja D; Reich J; Gezahegn S; Greer N; Shaukat A; MacDonald R; Rutks I; Wilt TJ
    Ann Intern Med; 2015 May; 162(9):630-8. PubMed ID: 25938992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers.
    Lo Vecchio A; Cohen MB
    Curr Opin Gastroenterol; 2014 Jan; 30(1):47-53. PubMed ID: 24275671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.
    Ott SJ; Waetzig GH; Rehman A; Moltzau-Anderson J; Bharti R; Grasis JA; Cassidy L; Tholey A; Fickenscher H; Seegert D; Rosenstiel P; Schreiber S
    Gastroenterology; 2017 Mar; 152(4):799-811.e7. PubMed ID: 27866880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Faecal microbiota transplantation in patients with
    Lahtinen P; Mattila E; Anttila VJ; Tillonen J; Teittinen M; Nevalainen P; Salminen S; Satokari R; Arkkila P
    World J Gastroenterol; 2017 Oct; 23(39):7174-7184. PubMed ID: 29093626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection--an observational cohort study.
    Satokari R; Mattila E; Kainulainen V; Arkkila PE
    Aliment Pharmacol Ther; 2015 Jan; 41(1):46-53. PubMed ID: 25355279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
    Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
    Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal microbiota transplantation in children with recurrent Clostridium difficile infection.
    Pierog A; Mencin A; Reilly NR
    Pediatr Infect Dis J; 2014 Nov; 33(11):1198-200. PubMed ID: 24853539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of Clostridium difficile infection complicated by acute respiratory distress syndrome treated with fecal microbiota transplantation.
    Kim JE; Gweon TG; Yeo CD; Cho YS; Kim GJ; Kim JY; Kim JW; Kim H; Lee HW; Lim T; Ham H; Oh HJ; Lee Y; Byeon J; Park SS
    World J Gastroenterol; 2014 Sep; 20(35):12687-90. PubMed ID: 25253977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.
    Kelly BJ; Tebas P
    Chest; 2018 Jan; 153(1):266-277. PubMed ID: 28923757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).
    Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL
    Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.
    Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM
    Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stool transplants: ready for prime time?
    Weissman JS; Coyle W
    Curr Gastroenterol Rep; 2012 Aug; 14(4):313-6. PubMed ID: 22585070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies.
    Furuya-Kanamori L; Doi SA; Paterson DL; Helms SK; Yakob L; McKenzie SJ; Garborg K; Emanuelsson F; Stollman N; Kronman MP; Clark J; Huber CA; Riley TV; Clements AC
    J Clin Gastroenterol; 2017 Feb; 51(2):145-150. PubMed ID: 26974758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.